StockNews.com Begins Coverage on Ampio Pharmaceuticals
| AMPEDelisted Stock | USD 0.24 0.01 4.35% |
About 55% of Ampio Pharm's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Ampio Pharm pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Ampio Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Ampio Pharm stock news signals to limit their universe of possible portfolio assets.
Ampio Pharm pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ampio daily returns and investor perception about the current price of Ampio Pharm as well as its diversification or hedging effects on your existing portfolios.
Ampio |
Investment analysts at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals in a research report issued to clients and investors on Thursday. The firm set a sell rating on the stock. Ampio Pharmaceuticals Price Performance About Ampio Pharmaceuticals Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for
Read at thelincolnianonline.com
 |
Ampio Pharm Fundamental Analysis
We analyze Ampio Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ampio Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ampio Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Ampio Pharm is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Ampio Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ampio Pharm pink sheet to make a market-neutral strategy. Peer analysis of Ampio Pharm could also be used in its relative valuation, which is a method of valuing Ampio Pharm by comparing valuation metrics with similar companies.
Peers
Ampio Pharm Related Equities
| CADL | Candel Therapeutics | 4.55 | ||||
| SYBX | Synlogic | 4.17 | ||||
| ANTX | AN2 Therapeutics | 3.70 | ||||
| ZVSA | ZyVersa Therapeutics | 4.07 | ||||
| PULM | Pulmatrix | 4.31 | ||||
| ACIU | AC Immune | 4.44 | ||||
| REVB | Revelation Biosciences | 4.92 | ||||
| RNAZ | Transcode Therapeutics | 4.99 | ||||
| QNRX | Quoin Pharmaceuticals | 6.06 | ||||
| PHIO | Phio Pharmaceuticals | 6.63 | ||||
| GLUE | Monte Rosa | 8.27 | ||||
| AKTX | Akari Therapeutics | 9.22 | ||||
| ZURA | Zura Bio | 9.96 | ||||
| SONN | Sonnet Biotherapeutics | 12.92 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Ampio Pink Sheet
If you are still planning to invest in Ampio Pharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ampio Pharm's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |